Document Detail


Oral administration of docosahexaenoic acid attenuates interleukin-1β response and clinical course of septic neonates.
MedLine Citation:
PMID:  22079797     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: To analyze cytokine responses and the clinical course of septic neonates orally supplemented with docosahexaenoic acid as well as to evaluate fatty acid incorporation into leukocytes. METHODS: A quasiexperimental study was conducted in neonates who developed sepsis following a surgical procedure. Selected neonates were randomly assigned to receive 100 mg docosahexaenoic acid (G-DHA) daily or olive oil (G-OO) as placebo for 14 d throughout a sepsis episode. At selection (baseline), blood samples were obtained to determine interleukin-1 (IL-1)β, interleukin-6 (IL-6), and tumor necrosis factor-α as well as the leucocyte fatty acid profile. Measurements were repeated at 7 (D7) and 14 d (D14) of follow-up. Within- and between-group comparisons were conducted with parametric statistics after logarithmic transformation. Repeated measurement analyses with a general linear model procedure were used, adjusting according to human milk intake, use of anti-inflammatory drugs, and nutritional status. RESULTS: Sixty-three neonates were included: 29 in G-DHA group and 34 in G-OO group. Although decreases of cytokines during hospitalization were similar in both groups, there was a greater decrease of IL-1β in the G-DHA group than in the G-OO group after adjusting by confounders (P = 0.028). Leukocyte docosahexaenoic acid increased from 4.96 ± 2.96 at baseline to 5.52 ± 3.05 and 5.92 ± 2.8 at D7 and D14, respectively, in the G-DHA group (P = 0.044). Illness severity was inversely associated with the proportion of docosahexaenoic acid in leukocytes throughout follow-up (P = 0.034). CONCLUSIONS: Oral supplementation with docosahexaenoic acid to neonates attenuates IL-1β response and the clinical course of sepsis. This may be an additional strategy to further benefit ill neonates even if they are not candidates for parenteral nutrition.
Authors:
Mardia López-Alarcón; Mariela Bernabe-García; Olivia Del Valle; Gabriel González-Moreno; Azucena Martínez-Basilea; Raúl Villegas
Related Documents :
22445267 - Effect of carbonate on anaerobic acidogenesis and fermentative hydrogen production from...
16594067 - What is molt-inhibiting hormone? the role of an ecdysteroidogenesis inhibitor in the cr...
22524687 - Simultaneous analysis of free phytosterols/-stanols and intact phytosteryl/stanyl fatty...
16661087 - Metabolism of l-tyrosine to 4-hydroxybenzaldehyde and 3-bromo-4-hydroxybenzaldehyde by ...
14989377 - Structural elucidation of fritillahupehin from bulbs of fritillaria hupehensis hsiao et...
10593497 - Selection of methylation procedures for quantitation of short-chain glycerol-bound comp...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-11-11
Journal Detail:
Title:  Nutrition (Burbank, Los Angeles County, Calif.)     Volume:  -     ISSN:  1873-1244     ISO Abbreviation:  -     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8802712     Medline TA:  Nutrition     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Unit of Research in Medical Nutrition, Pediatric Hospital, Centro Médico Nacional "Siglo XXI" Mexican Institute of Social Security, Mexico City, Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The level of arabinitol in autistic children after probiotic therapy.
Next Document:  Biocatalytic ketone reduction: A green and efficient access to enantiopure alcohols.